Patent Reform

Abbott Diabetes Care: No Leave to Accuse More Bayer Products

11.5.07 • 

In the Abbot Diabetes Care v. Roche Diagnostics case, Judge Jenkins denies Abbot’s request to accuse additional products made by co-defendant Bayer Healthcare of infringement.

Snickers for GSK, Candy Corn for the PTO

11.2.07 • 

GlaxoSmithKline wins a preliminary injunction to stop the implementation of the PTO’s new claims and continuation rules.

The Opposition to Patent Reform Grows

10.29.07 • 

Not all tech companies are in lock step with each other in the patent reform debate, as the Innovation Alliance has shown.

Too Late! Stay Denied in Fresenius Med. v. Baxter Int’l

10.21.07 • 

Fresenius annoys Judge Armstrong, who denies a stay in the case, which has been proceeding for more than four years.

Court Adopts Neither Party’s Construction of “Common Surface”

10.14.07 • 

The Court looks mainly to the specification in this very short claim construction of the one term “common surface.”

GlaxoSmithKline Calls Shenanigans on New Claims & Continuation Rules

10.12.07 • 

GlaxoSmithKline has reviewed the new USPTO rules. It their contention that the rules exceed the PTO’s authority and are unconstitutional.

Defense to Inequitable Conduct Waives Privilege

10.11.07 • 

Magistrate Judge Seeborg applies the sword-and-shield theory in the Micro Theraputics case.

FTC and DOJ Report on Antitrust and Intellectual Property

10.3.07 • 

An overview of the joint FTC/DOJ report, Antitrust Enforcement and Intellectual Property Rights: Promoting Innovation and Competition.

Tech LawForum, Sponsored by the High Tech Law Institute High Tech Law Institute, Santa Clara University School of Law